Publication:
Genetic overlap between type 1 diabetes and other autoimmune diseases.

Loading...
Thumbnail Image

Date

2022-08-12

Authors

Marquez, Ana
Martin, Javier

Advisors

Journal Title

Journal ISSN

Volume Title

Publisher

Springer
Metrics
Google Scholar
Export

Research Projects

Organizational Units

Journal Issue

Abstract

Type 1 diabetes (T1D) is a chronic disease caused by the destruction of pancreatic β cells, which is driven by autoreactive T lymphocytes. It has been described that a high proportion of T1D patients develop other autoimmune diseases (AIDs), such as autoimmune thyroid disease, celiac disease, or vitiligo, which suggests the existence of common etiological factors among these disorders. In this regard, genetic studies have identified a high number of loci consistently associated with T1D that also represent established genetic risk factors for other AIDs. In addition, studies focused on identifying the shared genetic component in autoimmunity have described several common susceptibility loci with a potential role in T1D. Elucidation of this genetic overlap has been useful in identifying key molecular pathways with a pathogenic role in multiple disorders. In this review, we summarize recent advances in understanding the shared genetic component between T1D and other AIDs and discuss how the identification of common pathogenic mechanisms can help in the development of new therapeutic approaches as well as in improving the use of existing drugs.

Description

MeSH Terms

Humans
Diabetes Mellitus, Type 1
Autoimmunity
Vitiligo
Celiac Disease
T-Lymphocytes
Autoimmune Diseases
Hashimoto Disease
Hypopigmentation
Chronic Disease
Risk Factors

DeCS Terms

Humanos
Linfocitos T
Vitíligo
Autoinmunidad
Diabetes Mellitus tipo 1
Enfermedad celíaca
Enfermedad crónica
Enfermedad de Hashimoto
Enfermedades autoinmunes
Factores de riesgo
Hipopigmentación

CIE Terms

Keywords

Genome-wide Association studies, Genetics, Type 1 diabetes, Autoimmune diseases

Citation

Márquez A, Martín J. Genetic overlap between type 1 diabetes and other autoimmune diseases. Semin Immunopathol. 2022 Jan;44(1):81-97.